Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery

Transfusion

Volumn 46, Issue 7, 2006, Pages 1112-1119

  Cuenca, Jorge ^b   García Erce, José A ^b   Martínez, Fernando ^b   Pérez Serrano, Luis ^b   Herrera, Antonio ^b   Muñoz, Manuel ^a  

^a GIEMSA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; BLEEDING; BLOOD; BLOOD SALVAGE; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CONTROLLED STUDY; ERYTHROCYTE COUNT; ERYTHROPOIESIS; EVALUATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; IRON METABOLISM; KNEE ARTHROPLASTY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE TREATMENT; RESTRICTIVE TRANSFUSION TRIGGER; UNWASHED SHED BLOOD;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; IRON; LENGTH OF STAY; MALE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 33746567794     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00859.x     Document Type: Article

References (35)

1. Kumar GS, Von Arx OA, Pozo JL. Rate of blood loss over 48 hours following total knee replacement. Knee 2005;12:307-9.
2. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003;43:459-69.
3. Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999;81-A:2-10.
4. Bong MR, Patel V, Chang E, et al. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004;19:281-7.
5. Perioperative blood transfusion for elective surgery [monograph on the Internet]. Guideline No. 54. Edinburgh: Scottish Intercollegiate Guidelines Network; 2001 [updated 2004]. Available from: http://www.sign.ac.uk/guidelines/ fulltext/54/index.html
6. Carless P, Moxey A, O'Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med 2004;14:123-44.
7. García-Erce JA, Solano VM, Cuenca J, Ortega P. La hemoglobina preoperatoria como único factor predictor de las necesidades transfusionales en la artroplastia de rodilla. Rev Esp Anestesiol Reanim 2002;49:254-60.
8. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 2002;84-A:216-20.
9. Cuenca J, García-Erce JA, Muñoz M, et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004;44:1447-52.
10. García-Erce JA, Cuenca J, Muñoz M, et al. Perioperative stimulation of erythropoiesis with ontravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture: a prospective observational study. Vox Sang 2005;88:235-43.
11. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. Centres for Disease Control definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8.
12. Weber EW, Slappendel R, Hémon Y, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005;22:249-57.
13. Sebastián C, Romero R, Olalla E, García-Vallejo JJ, Muñoz M. Postoperative blood salvage and reinfusion in spinal surgery. blood quality, effectiveness and impact on patient blood parameters. Eur Spine J 2000;9:458-65.
14. British Committee for Standards in Haematology. Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusion. Br J Haematol 2001;113:24-32.
15. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts - blood transfusion. N Engl J Med 1999;340:448-7.
16. Beutler E, Hoffbrand AV, Coo JD. Iron deficiency and overload. Hematology (Am Soc Hematol Educ Prog) 2003:40-6.
17. Spencer J, Thomas SR, Yardy G, Mukundan C, Barrington R. Are we overusing blood transfusing after elective joint replacement? A simple method to reduce the use of a scarce resource. Ann R Coll Surg Engl 2005;87:28-30.
18. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17.
19. Muñoz M, Ariza D, Garcerán MJ, Gómez A, Campos A. Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement. Arch Orthop Trauma Surg 2005;125:385-9.
20. Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol 2004;76:74-8.
21. Karkouti K, McCluskey SA, Evans L, et al. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anaesth 2005;52:362-8.
22. Couvret C, Laffon M, Baud A, et al. A restrictive use of both autologous donation and recombinant human erythropietin is an efficient policy for primary total hip or knee arthroplasty. Anesth Analg 2004;99:262-71.
23. Kourtzis N, Pafilas D, Kasimatis G. Blood saving protocol in elective total knee arthroplasty. Am J Surg 2004;187:261-7.
24. Minoda Y, Sakawa A, Fukuoka S, Tada K, Takaoka K. Blood management for patients with hemoglobin level lower than 130 g/l in total knee arthroplasty. Arch Orthop Trauma Surg 2004;124:317-9.
25. Müller U, Exadaktylos A, Roeder C, et al. Effect of a flow chart on the use of blood transfusions in primary total hip and knee replacement, prospective before and after study. Br Med J 2004;328:934-8.
26. Goodnough LT, Skikne B, Brugnara C. Eryhropoietin, iron, and erythropoiesis. Blood 2000;96:823-33.
27. Finch CA, Belloti V, Stray S, et al. Plasma ferritin determination as a diagnostic tool. West J Med 1986;145:657-63.
28. Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, Jusko WJ. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J Clin Pharmacol 2004;44:991-1002.
29. Muñoz M, Cobos A, Campos A, Ariza D, Muñoz E, Gómez A. Impact of postoperative shed blood transfusion, with or without leucocyte reduction, on acute-phase response to surgery for total knee replacement. Acta Anaesthesiol Scand 2005;49:1182-90.
30. Biesma DH, Van de Wiel A, Beguin Y, Kraaijenhagen RJ, Marx JJ. Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995;25:383-9.
31. Van Iperen CE, Kraaijenhagen RJ, Biesma DH, et al. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998;85:41-5.
32. Fleming RE, Bacon BR. Orchestration of iron homeostasis. N Engl J Med 2005;352:1741-4.
33. Bernière J, Dehullu JP, Gall O, Murat I. Le fer intraveineux dans le traitement de asémies postopératoires dans la chirurgie du rachis del l'enfant et de l'adolescent. Rev Chir Orthop Reparatrice Appar Mot 1998;84:319-22.
34. Bisbe E, Rodríguez C, Ruiz A, et al. Uso preoperatorio de hierro endovenoso: una nueva terapéutica en medicina transfusional. Rev Esp Anestesiol Reanim 2005;52:536-40.
35. Goodnough LT, Shander A, Spivak JL, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 2005;101:1858-61.